The global Rabeprazole Sodium market is expected to reach USD 1.5 billion by 2030.
Gastroesophageal reflux disease (GERD) is the most common disorder in the world and it affects more than 50 million people in North America alone. GERD treatment with Rabeprazole Sodium has been found to be effective in reducing symptoms such as heartburn and regurgitation of stomach acid into the esophagus, which can lead to ulcers or cancer of the esophagus if left untreated for long periods of time. GERD treatment with Rabeprazole Sodium has also been found to be effective in treating duodenal ulcer caused by Helicobacter pylori infection which can lead to gastric cancer if left untreated for long periods of time.
North America accounted for over 40% share of the global Rabeprazole Sodium market revenue in 2017 owing largely due its high prevalence rates and increasing awareness about GERD among patients and physicians alike coupled with growing adoption rates among patients suffering from GERD or duodenal ulcer disease (DD).
- Rabeprazole Sodium is a proton pump inhibitor that is used to treat gastroesophageal reflux disease, peptic ulcers, and other conditions.
- Rabeprazole Sodium has been approved by the FDA for use in adults and children over 12 years of age.
- Rabeprazole Sodium is available as a generic drug in the United States since December 2011.
- The US market for Rabeprazole Sodium was valued at $890 million in 2012.
Industry Growth Insights published a new data on “Rabeprazole Sodium Market”. The research report is titled “Rabeprazole Sodium Market research by Types (Rabeprazole Sodium Monohydrate, Rabeprazole Sodium Crystalline), By Applications (Gastroesophageal Reflux Disease Treatment, Duodenal Ulcer Treatment, Others), By Players/Companies JSN Chemicals, Jubilant Pharma, Smaart Pharmaceutticals, Shanghai Pharma Group Changzhou Kony Pharmaceutical, ASN Corporation, Intas, Sterile India, Zhejiang Yongtai Technology, Enal Drugs Private Limited, Syntech Chem?Pharm”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Rabeprazole Sodium Market Research Report
By Type
Rabeprazole Sodium Monohydrate, Rabeprazole Sodium Crystalline
By Application
Gastroesophageal Reflux Disease Treatment, Duodenal Ulcer Treatment, Others
By Companies
JSN Chemicals, Jubilant Pharma, Smaart Pharmaceutticals, Shanghai Pharma Group Changzhou Kony Pharmaceutical, ASN Corporation, Intas, Sterile India, Zhejiang Yongtai Technology, Enal Drugs Private Limited, Syntech Chem?Pharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Rabeprazole Sodium Market Report Segments:
The global Rabeprazole Sodium market is segmented on the basis of:
Types
Rabeprazole Sodium Monohydrate, Rabeprazole Sodium Crystalline
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Gastroesophageal Reflux Disease Treatment, Duodenal Ulcer Treatment, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- JSN Chemicals
- Jubilant Pharma
- Smaart Pharmaceutticals
- Shanghai Pharma Group Changzhou Kony Pharmaceutical
- ASN Corporation
- Intas
- Sterile India
- Zhejiang Yongtai Technology
- Enal Drugs Private Limited
- Syntech Chem?Pharm
Highlights of The Rabeprazole Sodium Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Rabeprazole Sodium Monohydrate
- Rabeprazole Sodium Crystalline
- By Application:
- Gastroesophageal Reflux Disease Treatment
- Duodenal Ulcer Treatment
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rabeprazole Sodium Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rabeprazole sodium is a proton pump inhibitor (PPI) that is used to treat gastroesophageal reflux disease (GERD). Rabeprazole sodium works by reducing the amount of acid produced in the stomach. This can help to reduce symptoms such as heartburn, regurgitation, and difficulty swallowing. Rabeprazole sodium may also be used for other purposes not listed here.
Some of the major players in the rabeprazole sodium market are JSN Chemicals, Jubilant Pharma, Smaart Pharmaceutticals, Shanghai Pharma Group Changzhou Kony Pharmaceutical, ASN Corporation, Intas, Sterile India, Zhejiang Yongtai Technology, Enal Drugs Private Limited, Syntech Chem?Pharm.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Rabeprazole Sodium Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Rabeprazole Sodium Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Rabeprazole Sodium Market - Supply Chain
4.5. Global Rabeprazole Sodium Market Forecast
4.5.1. Rabeprazole Sodium Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Rabeprazole Sodium Market Size (000 Units) and Y-o-Y Growth
4.5.3. Rabeprazole Sodium Market Absolute $ Opportunity
5. Global Rabeprazole Sodium Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Rabeprazole Sodium Market Size and Volume Forecast by Type
5.3.1. Rabeprazole Sodium Monohydrate
5.3.2. Rabeprazole Sodium Crystalline
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Rabeprazole Sodium Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Rabeprazole Sodium Market Size and Volume Forecast by Application
6.3.1. Gastroesophageal Reflux Disease Treatment
6.3.2. Duodenal Ulcer Treatment
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Rabeprazole Sodium Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Rabeprazole Sodium Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Rabeprazole Sodium Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Rabeprazole Sodium Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Rabeprazole Sodium Demand Share Forecast, 2019-2026
9. North America Rabeprazole Sodium Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Rabeprazole Sodium Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Rabeprazole Sodium Market Size and Volume Forecast by Application
9.4.1. Gastroesophageal Reflux Disease Treatment
9.4.2. Duodenal Ulcer Treatment
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Rabeprazole Sodium Market Size and Volume Forecast by Type
9.7.1. Rabeprazole Sodium Monohydrate
9.7.2. Rabeprazole Sodium Crystalline
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Rabeprazole Sodium Demand Share Forecast, 2019-2026
10. Latin America Rabeprazole Sodium Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Rabeprazole Sodium Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Rabeprazole Sodium Market Size and Volume Forecast by Application
10.4.1. Gastroesophageal Reflux Disease Treatment
10.4.2. Duodenal Ulcer Treatment
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Rabeprazole Sodium Market Size and Volume Forecast by Type
10.7.1. Rabeprazole Sodium Monohydrate
10.7.2. Rabeprazole Sodium Crystalline
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Rabeprazole Sodium Demand Share Forecast, 2019-2026
11. Europe Rabeprazole Sodium Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Rabeprazole Sodium Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Rabeprazole Sodium Market Size and Volume Forecast by Application
11.4.1. Gastroesophageal Reflux Disease Treatment
11.4.2. Duodenal Ulcer Treatment
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Rabeprazole Sodium Market Size and Volume Forecast by Type
11.7.1. Rabeprazole Sodium Monohydrate
11.7.2. Rabeprazole Sodium Crystalline
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Rabeprazole Sodium Demand Share, 2019-2026
12. Asia Pacific Rabeprazole Sodium Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Rabeprazole Sodium Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Rabeprazole Sodium Market Size and Volume Forecast by Application
12.4.1. Gastroesophageal Reflux Disease Treatment
12.4.2. Duodenal Ulcer Treatment
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Rabeprazole Sodium Market Size and Volume Forecast by Type
12.7.1. Rabeprazole Sodium Monohydrate
12.7.2. Rabeprazole Sodium Crystalline
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Rabeprazole Sodium Demand Share, 2019-2026
13. Middle East & Africa Rabeprazole Sodium Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Rabeprazole Sodium Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Rabeprazole Sodium Market Size and Volume Forecast by Application
13.4.1. Gastroesophageal Reflux Disease Treatment
13.4.2. Duodenal Ulcer Treatment
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Rabeprazole Sodium Market Size and Volume Forecast by Type
13.7.1. Rabeprazole Sodium Monohydrate
13.7.2. Rabeprazole Sodium Crystalline
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Rabeprazole Sodium Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Rabeprazole Sodium Market: Market Share Analysis
14.2. Rabeprazole Sodium Distributors and Customers
14.3. Rabeprazole Sodium Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. JSN Chemicals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Jubilant Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Smaart Pharmaceutticals
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Shanghai Pharma Group Changzhou Kony Pharmaceutical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ASN Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Intas
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sterile India
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Zhejiang Yongtai Technology
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Enal Drugs Private Limited
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Syntech Chem?Pharm
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
